respiratory disease

AstraZeneca Highlights Long-Acting Antibodies and Vaccines for At-Risk Individuals at IDWeek Conference

(IN BRIEF) AstraZeneca is set to present new data at the 12th annual IDWeek conference, emphasizing the role of long-acting…

7 months ago

NORMA Group CEO Dr. Michael Schneider currently receiving medical treatment for COVID-19; COO Dr. Friedrich Klein temporarily assumes CEO role

Dr. Michael Schneider cannot perform his tasks for the time being COO Dr. Friedrich Klein temporarily assumes the tasks of…

4 years ago

GlaxoSmithKline to present comprehensive portfolio of respiratory research and scientific innovation at the American Thoracic Society (ATS) conference

Brentford, United Kingdom, 17-May-2018 — /EuropaWire/ — GlaxoSmithKline plc (GSK) will present extensive data from across its respiratory portfolio, pipeline and…

6 years ago